Voloridge Investment Management
IMNM icon

Voloridge Investment Management’s Immunome IMNM Stock Holding History

Voloridge Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,282
Closed -$245K – 1256
2024
Q2 		$245K Buy
+20,282
New +$317K ﹤0.01% 1160

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Voloridge Investment Management's IMNM Position: Q3 2024 in Review

Voloridge Investment Management sold out of Immunome (IMNM) in Q3 2024, closing a stake of 20,282 shares — an estimated $245K sold.

Voloridge Investment Management first reported a position in IMNM in Q2 2024 and held it in 1 quarter. The position peaked at $245K in Q2 2024. 115 funds tracked by Wall St. Rank hold IMNM as of Q3 2024.

  • Voloridge Investment Management reported no remaining Immunome position as of Q3 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 20,282 Immunome shares in Q3 2024, an estimated $245K.
  • Voloridge Investment Management first reported a position in Immunome in Q2 2024 and held it in 1 quarter.
  • Voloridge Investment Management's Immunome position peaked at $245K in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Immunome as of Q3 2024.

Based on Voloridge Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.